
Chief Marketing Officer departs Lazar
It is with mixed emotions that I announce the departure of Kate (Kathryn) Ross, Chief Marketing Officer at Lazar Pharmaceuticals since the company was founded in 2001.
Ross and the Lazar Pharmaceuticals Board of Directors came to a mutual agreement last evening that effective immediately they would part ways. I am not at liberty at this time to discuss the circumstances surrounding Ross’ departure, or comment on rumors that she leaked proprietary information related to the recent disappearances of two individuals involved in Lazar’s clinical trials.